The hospital pharmacy leader and the fight against drug diversion — A panel discussion on new tools and guidelines

Wednesday, April 28th, 2021 | 2:00 PM - 3:00 PM CT

Drug diversion remains a major concern for hospital pharmacy teams and can cause increased risks for clinicians, patients and organizations. In response to the severity of the problem, pharmaceutical governing organizations will release new guidelines outlining best practices for diversion detection and investigations as well as a statement on the use of artificial intelligence in pharmacy.

This session will feature a panel discussion with diversion experts who will examine the problem of drug diversion and anticipated best practices for adhering to the pending guidelines.

Following the session, attendees will better understand:
  • The potential impact of the upcoming new guidelines for diversion
  • How to build diversion processes
  • Key members and roles of the team
  • The benefits of automation, machine learning, and artificial intelligence to identify diversion



Julia Schimmelpfennig

Julia Schimmelpfennig

PharmD, MS, BCPS, CDE, Pharmacy Director, St. Elizabeth's Hospital, Hospital Sisters Health System

janice-ahlstrom - Kristelle Khazzaka

Janice Ahlstrom

FHIMSS, CPHIMS, CCSFP, RN, BSN, Director, Risk Advisory Services, Baker Tilly

patrick-yoder - Kristelle Khazzaka

Patrick Yoder

PharmD, Co-founder and Chief Executive Officer, LogicStream Health

unnamed (1)

Andy Schuelke

PharmD, Regional Informatics Pharmacist, St. Vincent Healthcare, SCL Health - Montana